Cellectis SA (CLLS)
1.845
-0.02
(-0.81%)
USD |
NASDAQ |
Nov 22, 11:26
Cellectis 1 Year Total Returns (Daily): -34.51% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | -34.51% |
November 20, 2024 | -38.39% |
November 19, 2024 | -33.11% |
November 18, 2024 | -33.79% |
November 15, 2024 | -33.21% |
November 14, 2024 | -25.39% |
November 13, 2024 | -21.43% |
November 12, 2024 | -21.31% |
November 11, 2024 | -23.90% |
November 08, 2024 | -29.20% |
November 07, 2024 | -26.78% |
November 06, 2024 | -35.87% |
November 05, 2024 | -37.76% |
November 04, 2024 | -38.46% |
November 01, 2024 | -31.82% |
October 31, 2024 | 83.51% |
October 30, 2024 | 79.28% |
October 29, 2024 | 81.51% |
October 28, 2024 | 91.43% |
October 25, 2024 | 86.00% |
October 24, 2024 | 80.95% |
October 23, 2024 | 64.17% |
October 22, 2024 | 48.76% |
October 21, 2024 | 51.65% |
October 18, 2024 | 42.86% |
Date | Value |
---|---|
October 17, 2024 | 41.48% |
October 16, 2024 | 38.69% |
October 15, 2024 | 36.96% |
October 14, 2024 | 41.30% |
October 11, 2024 | 43.06% |
October 10, 2024 | 37.93% |
October 09, 2024 | 36.36% |
October 08, 2024 | 35.17% |
October 07, 2024 | 35.86% |
October 04, 2024 | 33.38% |
October 03, 2024 | 28.57% |
October 02, 2024 | 30.67% |
October 01, 2024 | 27.85% |
September 30, 2024 | 34.18% |
September 27, 2024 | 36.50% |
September 26, 2024 | 35.19% |
September 25, 2024 | 35.00% |
September 24, 2024 | 28.49% |
September 23, 2024 | 27.91% |
September 20, 2024 | 38.47% |
September 19, 2024 | 41.46% |
September 18, 2024 | 39.88% |
September 17, 2024 | 36.05% |
September 16, 2024 | 33.72% |
September 13, 2024 | 27.84% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.75%
Minimum
Jun 14 2022
172.9%
Maximum
Mar 22 2021
-13.52%
Average
-20.00%
Median
1 Year Total Returns (Daily) Benchmarks
Edap TMS SA | -44.04% |
DBV Technologies SA | -69.87% |
Genfit SA | 32.92% |
Adaptimmune Therapeutics PLC | 44.19% |
Akari Therapeutics PLC | -59.35% |